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.Introduction: There is no evidence on which to base the ideal technique for the treatment of aorto-enteric
ﬁstulas (AEFs).
Report: A 54-year-old man presented with an AEF. He had previously undergone aortobifemoral bypass with an
end-to-side proximal anastomosis. An Endurant II aorto-uni-iliac endograft and a Complete SE stent soaked in
rifampicin were implanted. After 12 hours, a second staged intervention was performed. The original graft was
removed and the communication with the duodenum was repaired.
Discussion: A staged combination of endovascular repair for acute bleeding control and open surgical treatment,
combined with systemic and local antibiotics might be considered the option of choice.
 2014 European Society for Vascular Surgery. Published by Elsevier Ltd.
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Secondary aortoenteric ﬁstula (AEF) is deﬁned as that
occurring after a previous aortic reconstructive surgery. The
mortality rate is signiﬁcant either from massive haemor-
rhage or profound systemic infection and sepsis.1
Endovascular repair is a seemingly attractive option as it
confers much less trauma in the acute situation. The major
concern with this endoluminal strategy is the persisting
synthetic material from the original operation, because one
of the hallmarks of conventional treatment is the removal
of the infected graft.REPORT
A 54-year-old man presented with an episode of haema-
temesis, fever, and back pain. On admission he was in
haemodynamic shock and severely anaemic. His blood
pressure was 95/45, pulse 112, and haemoglobin level
5.8 g/dL. Five years before, he had undergone an aortobi-
femoral bypass for intermittent claudication with type D
TASC II lesions.2 The conﬁguration of the proximal anasto-
mosis was end-to-side. Abdominal computed tomographic
angiography (angio-CT) depicted a secondary AEF (Fig. 1).
Under general anaesthesia the femoral arteries and the
distal femoral limbs of the vascular graft were exposed. The
iliac lesions and the aortic occlusion were crossed with a
0.035-inch hydrophilic guidewire (Radiofocus M; Terumo,
Leuven, Belgium) supported by a 4F CXI support catheterof original article: http://dx.doi.org/10.1016/j.ejvs.2014.01.009
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second stiffer wire (Amplatz Super Stiff; Boston Scientiﬁc,
Natick, MA, USA) was exchanged through the catheter to
facilitate the predilatation of the aorta, right common and
external iliac arteries (XXL balloon catheter and Ultra-thin
Diamond balloon catheter, Boston Scientiﬁc). After the an-
gioplasty, an endurant II aorto-uni-iliac endoprosthesis
(25  14  102 mm, Medtronic Ave, Inc, Santa Rosa, CA,
USA) and a Complete SE iliac stent (10  80 mm, Medtronic
Ave) soaked in rifampicin were delivered. Angiography
demonstrated regular ﬂow through the endograft and
complete exclusion of the AEF. A prosthetic femoro-femoral
bypass with Dacron soaked in rifampicin was performed.
Broad-spectrum intravenous antibiotics and antifungal
treatment were administered. The patient was transferred
to the intensive care unit (ICU) where he was sedated and
mechanically ventilated. Four units of red blood cells and
one of platelets were transfused.
After 12 hours, with a more stable haemodynamic con-
dition, a second staged procedure was performed through a
midline laparotomy. The original graft was removed with
the proximal anastomosis covered by the stent-graft. During
surgery, specimens were taken for bacteriological analysis,
and all the excised prosthetic graft was sent for culture
(positive for Klebsiella oxytoca and Streptococcus angino-
sus). The parietal defect of the aorta was closed with a
bovine pericardial patch (Vascu-Guard, Synovis Surgical In-
novations, St. Paul, MN, USA) (Fig. 2). The communication
with the duodenum was repaired with a direct suture and
the greater omentum was mobilized to cover the aortic
patch.
The patient recovered from the procedure without
complication and was discharged 11 days after the ﬁrst
intervention. Oral linezolid and levoﬂoxacin were
continued for 4 weeks, ceftoditoren for 3 months, and
cloxacillin for another 3 months. The angio-CT performed
Figure 1. Computed tomography with intravenous contrast showing effacement of the periaortic fat plane and contrast extravasation into
the duodenum (arrow).
Figure 2. Left: Operative photograph showing the endograft (white arrow) and the pericardial bovine patch (black arrow) used to cover the
parietal defect in the aorta. Right: 3D reconstruction computed tomography angiogram 1 year after the “two-step” procedure. No evidence
of infection is seen.
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plications (Fig. 2). A 99mTC-labelled white cell scan at 12
months was normal.
DISCUSSION
Open surgical treatment of a secondary AEF has tradi-
tionally been associated with a high mortality. Endovas-
cular treatment options include placement of an aorto-
aortic tube stent-graft, an aorto-uni-iliac device com-
bined with a femoral-femoral crossover graft, or a bifur-
cated aortic stent-graft with suprarenal ﬁxation inside the
existing graft.3
In the systematic review published by Antoniou et al.,4 of
the outcome of endovascular stent graft repair of AEF, 51%
of the patients developed complications, and 30% died
during follow-up, most as a result of septic complications. A
multicentre retrospective comparative study published in
20115 reported fewer complications and lower mortality in
the endovascular group, but this short-term advantage was
lost during the second postprocedural year because of
infective complications.
This staged surgical repair is in accordance with classical
principles: prevent haemorrhage and excise all infected
tissue, while restoring perfusion to the legs. During the ﬁrst
stage, endovascular repair provides rapid control of hae-
morrhage, offering valuable time to optimize medical con-
ditions, and maintain adequate distal perfusion. At the
second stage, the previous infected tissues and graft are
removed, providing control of infection, by performing alaparotomy in a stabilized setting. During this step, intesti-
nal repair is performed. The difference between this and
other endovascular strategies is the previous graft total
excision, diminishing the risk of infection of the new stent-
graft.
Despite these advantages, placement of an endograft in
an infected bed remains a major concern. Lifelong oral
antibiotics are necessary. This staged intervention might be
considered the option of choice in patients with end-to-side
aortic anastomosis and TASC C-D lesions. Further research
to deﬁne the appropriate management of AEFs with open
surgical procedures, endovascular repair or combined
methods is necessary.FUNDING
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